祛瘀生肌方通过Caspase信号通路促进糖尿病溃疡上皮化愈合的机制研究

基本信息
批准号:81503587
项目类别:青年科学基金项目
资助金额:18.00
负责人:姜文成
学科分类:
依托单位:同济大学
批准年份:2015
结题年份:2018
起止时间:2016-01-01 - 2018-12-31
项目状态: 已结题
项目参与者:茅伟安,王莉,张健,周洁,王立娟,孙圆圆
关键词:
Bcl2糖尿病溃疡Caspase信号通路甲基化祛瘀生肌方
结项摘要

Diabetes ulcer is one of the most serious complications of diabetes with less safe and effective treatment. Formula of Stasis Correction and Granulation Promotion is confirmed effective for the disease.We propose the hypothesis“ The key mechanism of Formula of Stasis Correction and Granulation Promotion promoting the production of diabetic ulcers epithelial healing is the Bcl-2 gene methylation regulation in Caspase signaling pathways”based on the preliminary results that the Formula inhibit the abnormal keratinocyte proliferation through cell apoptosis in Caspase signaling pathways.In vivo experiment,MSP,RT-PCR,immunohistochemical,Westernblot is used to observe diabetic ulcer animal model,KC Bcl-2 mathylation degree and Caspase3 gene expression,reveal the mechanism of Bcl-2 methylation activating caspase pathway apoptosis to regulate KC proliferation.In vitro experiment,siRNA interference and demethylation is used to observe KC morphology and function intervened by medical serum,verify the effects Bcl-2 methylation regulating Caspase pathway on KC apoptosis and proliferation.In all above,through research, to clarify the relationship between Formula of Stasis Correction and Granulation Promotion promoting the diabetic ulcers epithelial healing and the Bcl-2 methylation regulating the Caspase pathway.This study will further enrich our view of “removal of stasis is beneficial for the growth of new tissues ”.

糖尿病溃疡是糖尿病最严重的并发症之一,缺乏安全有效的治疗药物。课题组运用 “祛瘀生肌方”治疗本病临床疗效显著,在明确该方通过Caspase凋亡途径抑制角质形成细胞异常增殖的基础上,提出“祛瘀生肌方促进糖尿病溃疡上皮化愈合的关键环节是Bcl-2基因甲基化调控Caspase信号通路”的假说。在体实验运用MSP、RT-PCR、免疫组化、Westernblot,观察糖尿病溃疡愈合及角质形成细胞Bcl-2甲基化程度、Caspase3基因表达,揭示Bcl-2甲基化致Caspase通路活化进而调控角质形成细胞增殖的机制;离体实验运用siRNA干扰和去甲基化技术,观察经药血清干预的角质形成细胞形态功能,验证Bcl-2甲基化调控Caspase通路对细胞凋亡、增殖的影响。综上阐明祛瘀生肌方促进糖尿病溃疡上皮化愈合与Bcl-2甲基化调控Caspase信号通路的关系,丰富“祛瘀利于生肌”学术观点的科学内涵。

项目摘要

糖尿病溃疡是糖尿病最严重的并发症之一,缺乏安全有效的治疗药物。课题组运用 “祛瘀生肌方”治疗本病临床疗效显著,前期研究已明确该方通过Caspase凋亡途径抑制角质形成细胞异常增殖。通过本项目的研究,在体实验运用MSP、RT-PCR、免疫组化、Westernblot,观察到“祛瘀生肌方”组糖尿病溃疡愈合程度及角质形成细胞Bcl-2甲基化程度、Caspase3基因表达均高于对照组,揭示Bcl-2甲基化致Caspase通路活化进而调控角质形成细胞增殖的机制;离体实验运用siRNA干扰和去甲基化技术,观察到经“祛瘀生肌方”药血清干预的角质形成细胞增值凋亡,验证了Bcl-2甲基化调控Caspase通路对细胞凋亡、增殖的影响。综上,本研究阐明祛瘀生肌方促进糖尿病溃疡上皮化愈合与Bcl-2甲基化调控Caspase信号通路的关系,初步证实了“祛瘀生肌方促进糖尿病溃疡上皮化愈合的关键环节是Bcl-2基因甲基化调控Caspase信号通路”,为“祛瘀利于生肌”的学术观点提供了新的分子生物学证据,丰富了其科学内涵。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation

Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation

DOI:
发表时间:2016
2

Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling

Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling

DOI:10.1016/j.intimp.2021.107374
发表时间:2021
3

An alternative conformation of human TrpRS suggests a role of zinc in activating non-enzymatic function

An alternative conformation of human TrpRS suggests a role of zinc in activating non-enzymatic function

DOI:10.1080/15476286.2017.1377868.
发表时间:2017
4

基于分形维数和支持向量机的串联电弧故障诊断方法

基于分形维数和支持向量机的串联电弧故障诊断方法

DOI:
发表时间:2016
5

Baicalin provides neuroprotection in traumatic brain injury mice model through Akt/Nrf2 pathway

Baicalin provides neuroprotection in traumatic brain injury mice model through Akt/Nrf2 pathway

DOI:10.2147/DDDT.S163951
发表时间:2018

姜文成的其他基金

相似国自然基金

1

祛瘀生肌法促进糖尿病溃疡上皮化功能的相关机制研究

批准号:81102596
批准年份:2011
负责人:李福伦
学科分类:H3109
资助金额:21.00
项目类别:青年科学基金项目
2

祛瘀生肌法通过Follistatin/Activin信号通路改善糖尿病溃疡炎症微环境的相关机制研究

批准号:81673866
批准年份:2016
负责人:李福伦
学科分类:H3104
资助金额:55.00
项目类别:面上项目
3

生肌象皮膏促进糖尿病溃疡愈合的免疫-炎症机制研究

批准号:81072817
批准年份:2010
负责人:李巧芬
学科分类:H3109
资助金额:33.00
项目类别:面上项目
4

Smad7与β-catenin在糖尿病溃疡创面上皮化进程中的作用及祛瘀生肌中药干预研究

批准号:81373648
批准年份:2013
负责人:李福伦
学科分类:H3109
资助金额:70.00
项目类别:面上项目